1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Autor:	Reck, M. 1, Mileham, K.F. 2, Clump, D.A. 3, Decoster, L. 4, Estival, A. 5, Felip, E. 6, Fried, P. 7, Paz-Ares, L. 8, Sebastian, M. 9, Segarra, N. Vinolas 10, Surmont, V. 11, Wagner, A. 12, Galdy, S.M. 13, Smit, E.F. 14
Zdroj:	In Annals of Oncology September 2020 31 Supplement 4:S897-S898
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu